Tobias Langenhan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Recognitions
Tobias Langenhan has a total of 603 co-authors. Here are the top co-authors by number of shared publications:
- Nicole Scholz
Rudolf Schönheimer Institute of Biochemistry, Division of General Biochemistry, Medical Faculty, Leipzig University, 04103 Leipzig, Germany
16 shared publications - Robert J. Kittel
Leipzig University
13 shared publications - Simone Prömel
Institute of Cell Biology, Department of Biology, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
10 shared publications Torsten Schöneberg
Rudolf-Schonheimer-Institute of Biochemistry, Division of Molecular Biochemistry, Leipzig University
9 shared publications- Torsten Schöneberg
Leipzig University Leipzig Germany
9 shared publications - Florian Seufert
Institute of Medical Physics and Biophysics, Leipzig University, Leipzig, Germany
7 shared publications
Latest Publications
- Open Access
- 6 April 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Structural basis of GAIN domain autoproteolysis and cleavage-resistance in the adhesion G-protein coupled receptors
The GAIN domain is a hallmark of adhesion G protein-coupled receptors (aGPCRs), as this extracellular domain contains an integral agonistic sequence ( Stachel ) that activates the receptor by binding to its 7-transmembrane helix (7TM) domain. Many aGPCRs undergo autoproteolytic cleavage at the GPCR proteolysis site (GPS), which has a canonical H-X-S/T sequence motif located within the GPCR autoproteolysis-inducing (GAIN) domain. Here we present the crystal structure of the Hormone Receptor (HormR) and GAIN domains of ADGRB2/BAI2. The protein was not cleaved at the GPS, despite possessing an HLS sequence. Through structural comparisons and molecular dynamics (MD) simulations, we identify determinants that contribute to autoproteolytic activity beyond the H-X-S/T motif. Specifically, we highlight a T-shaped π–π interaction between the histidine base of the H-X-S/T motif and a phenylalanine residue that is highly conserved in cleavage-competent aGPCRs. This interaction is critical for properly positioning the imidazole group of the histidine to deprotonate the alcohol nucleophile. Disruption of this interaction reduces autoproteolytic activity in the ADGRL1 and introduction of the phenylalanine restores cleavage competence in the otherwise non-cleavable ADGRB3 upon expression in HEK293 cells. In addition, the poorly conserved and flexible flap regions flanking the GPS also contribute to full autocleavage activity.
- 6 April 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessStructural basis of GAIN domain autoproteolysis and cleavage-resistance in the adhesion G-protein coupled receptors
The GAIN domain is a hallmark of adhesion G protein-coupled receptors (aGPCRs), as this extracellular domain contains an integral agonistic sequence ( Stachel ) that activates the receptor by binding to its 7-transmembrane helix (7TM) domain. Many aGPCRs undergo autoproteolytic cleavage at the GPCR proteolysis site (GPS), which has a canonical H-X-S/T sequence motif located within the GPCR autoproteolysis-inducing (GAIN) domain. Here we present the crystal structure of the Hormone Receptor (HormR) and GAIN domains of ADGRB2/BAI2. The protein was not cleaved at the GPS, despite possessing an HLS sequence. Through structural comparisons and molecular dynamics (MD) simulations, we identify determinants that contribute to autoproteolytic activity beyond the H-X-S/T motif. Specifically, we highlight a T-shaped π–π interaction between the histidine base of the H-X-S/T motif and a phenylalanine residue that is highly conserved in cleavage-competent aGPCRs. This interaction is critical for properly positioning the imidazole group of the histidine to deprotonate the alcohol nucleophile. Disruption of this interaction reduces autoproteolytic activity in the ADGRL1 and introduction of the phenylalanine restores cleavage competence in the otherwise non-cleavable ADGRB3 upon expression in HEK293 cells. In addition, the poorly conserved and flexible flap regions flanking the GPS also contribute to full autocleavage activity.
- 17 February 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Signaling
- Vol. 19 (925) , eaed6070
The elephant in the adhesion GPCR room
Adhesion GPCRs are a family of surface receptors involved in many developmental and physiological decisions in every organ system. In this issue of Science Signaling , Bernadyn et al. report insights into the activation mechanism and cellular functions of the adhesion GPCR GPR97/ADGRG3.
- 17 February 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Signaling
- Vol. 19 (925) , eaed6070
The elephant in the adhesion GPCR room
Adhesion GPCRs are a family of surface receptors involved in many developmental and physiological decisions in every organ system. In this issue of Science Signaling , Bernadyn et al. report insights into the activation mechanism and cellular functions of the adhesion GPCR GPR97/ADGRG3.
- Open Access
- 16 January 2026
- Published by Elsevier in Pharmacological Reviews
- Vol. 78 (3) , 100116
Adhesion G protein-coupled receptors
- 16 January 2026
- Published by Elsevier in Pharmacological Reviews
- Vol. 78 (3) , 100116
Open AccessAdhesion G protein-coupled receptors
- Top Cited PapersOpen Access
- 29 December 2025
- Published by Wiley in British Journal of Pharmacology
- Vol. 182 (S1) , S24-S151
The Concise Guide to PHARMACOLOGY 2025/26: G protein‐coupled receptors
The Concise Guide to Pharmacology 2025/26 marks the seventh edition in this series of biennial publications in the British Journal of Pharmacology. Presented in landscape format, the guide provides a comparative overview of the pharmacology of drug target families. The concise nature of the Concise Guide refers to the style of presentation, being clear, accessible, and well‐structured, rather than the scope of the content, which spans approximately 500 pages. The Concise Guide summarises the key pharmacological properties of around 1900 human drug targets, and nearly 7000 interactions, involving around 4400 ligands. While the content is a substantially condensed version of the more detailed information and links available at the www.guidetopharmacology.org website, the printed guide serves as a permanent, citable, point‐in‐time record, that remains stable despite ongoing updates to the online database. The full contents of this publication can be found at https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bph.70230 . The Concise Guides provide expert‐curated recommendations of ‘Gold Standard’ selective pharmacological tools, available either commercially or as donations, which enable the identification of individual drug targets or families of drug targets. While the Concise Guide offers a more streamlined overview, more comprehensive information, including detailed pharmacological profiles and links to multiple online databases, is available through the Guide to Pharmacology website. The 2025/26 edition of the Concise Guide is based on material current as of mid‐2025, and supersedes all previous editions, including the 2023/24 Guide, and earlier Guides to Receptors and Channels. It is produced in close conjunction with the Nomenclature and Standards Committee of the International Union of Basic and Clinical Pharmacology (NC‐IUPHAR), and as such provides official IUPHAR classification and nomenclature for human drug targets, where applicable. G protein‐coupled receptors are one of the six major pharmacological targets into which the Guide is divided, with the others being: ion channels, nuclear hormone receptors, catalytic receptors, enzymes and transporters. Each section includes nomenclature guidance, concise summaries, information of the best available pharmacological tools, key references, and suggestions for further reading.
- 29 December 2025
- Published by Wiley in British Journal of Pharmacology
- Vol. 182 (S1) , S24-S151
Top Cited PapersOpen AccessThe Concise Guide to PHARMACOLOGY 2025/26: G protein‐coupled receptors
The Concise Guide to Pharmacology 2025/26 marks the seventh edition in this series of biennial publications in the British Journal of Pharmacology. Presented in landscape format, the guide provides a comparative overview of the pharmacology of drug target families. The concise nature of the Concise Guide refers to the style of presentation, being clear, accessible, and well‐structured, rather than the scope of the content, which spans approximately 500 pages. The Concise Guide summarises the key pharmacological properties of around 1900 human drug targets, and nearly 7000 interactions, involving around 4400 ligands. While the content is a substantially condensed version of the more detailed information and links available at the www.guidetopharmacology.org website, the printed guide serves as a permanent, citable, point‐in‐time record, that remains stable despite ongoing updates to the online database. The full contents of this publication can be found at https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bph.70230 . The Concise Guides provide expert‐curated recommendations of ‘Gold Standard’ selective pharmacological tools, available either commercially or as donations, which enable the identification of individual drug targets or families of drug targets. While the Concise Guide offers a more streamlined overview, more comprehensive information, including detailed pharmacological profiles and links to multiple online databases, is available through the Guide to Pharmacology website. The 2025/26 edition of the Concise Guide is based on material current as of mid‐2025, and supersedes all previous editions, including the 2023/24 Guide, and earlier Guides to Receptors and Channels. It is produced in close conjunction with the Nomenclature and Standards Committee of the International Union of Basic and Clinical Pharmacology (NC‐IUPHAR), and as such provides official IUPHAR classification and nomenclature for human drug targets, where applicable. G protein‐coupled receptors are one of the six major pharmacological targets into which the Guide is divided, with the others being: ion channels, nuclear hormone receptors, catalytic receptors, enzymes and transporters. Each section includes nomenclature guidance, concise summaries, information of the best available pharmacological tools, key references, and suggestions for further reading.
- Open Access
- 28 November 2025
- Published by Elsevier in Biochemistry and Biophysics Reports
- Vol. 45, 102375
Single nucleotide variants in UNC13C associated with neurodevelopmental disorders affect ethanol sensitivity in Drosophila
- 28 November 2025
- Published by Elsevier in Biochemistry and Biophysics Reports
- Vol. 45, 102375
Open AccessSingle nucleotide variants in UNC13C associated with neurodevelopmental disorders affect ethanol sensitivity in Drosophila
- Open Access
- 1 October 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-16
Self-cleavage of the GAIN domain of adhesion G protein-coupled receptors requires multiple domain-extrinsic factors
The autoproteolysis-inducing (GAIN) domain of class B2/adhesion G protein-coupled receptors (aGPCRs) is structurally conserved, and its self-cleavage is central to receptor mechanotransduction and signaling. Yet, the influence of factors beyond the protein fold on GAIN domain autoproteolysis remains unclear. Using ADGRE2/EMR2, a self-cleaved aGPCR, we investigated contributions of the seven-transmembrane (7TM) region to GAIN domain autoproteolysis during receptor maturation and trafficking. Retention Upon Selective Hook (RUSH) assays showed that self-cleavage acts as a checkpoint before endoplasmic reticulum (ER) exit, but not during plasma membrane transport. Stepwise truncations of the 7TM domain revealed that cleavage can occur before or at synthesis of the first transmembrane helix, and is enhanced with formation of the full 7TM domain. Analyses of six additional cleavage-competent aGPCRs demonstrated that ER membrane tethering facilitates GAIN domain processing, supported by proteomic evidence linking cleavage to proximity with the N-glycosylation pathway. These results highlight the interplay between GAIN and 7TM domains, offering mechanistic insights and guiding pharmacological strategies to modulate aGPCR activation and signaling.
- 1 October 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-16
Open AccessSelf-cleavage of the GAIN domain of adhesion G protein-coupled receptors requires multiple domain-extrinsic factors
The autoproteolysis-inducing (GAIN) domain of class B2/adhesion G protein-coupled receptors (aGPCRs) is structurally conserved, and its self-cleavage is central to receptor mechanotransduction and signaling. Yet, the influence of factors beyond the protein fold on GAIN domain autoproteolysis remains unclear. Using ADGRE2/EMR2, a self-cleaved aGPCR, we investigated contributions of the seven-transmembrane (7TM) region to GAIN domain autoproteolysis during receptor maturation and trafficking. Retention Upon Selective Hook (RUSH) assays showed that self-cleavage acts as a checkpoint before endoplasmic reticulum (ER) exit, but not during plasma membrane transport. Stepwise truncations of the 7TM domain revealed that cleavage can occur before or at synthesis of the first transmembrane helix, and is enhanced with formation of the full 7TM domain. Analyses of six additional cleavage-competent aGPCRs demonstrated that ER membrane tethering facilitates GAIN domain processing, supported by proteomic evidence linking cleavage to proximity with the N-glycosylation pathway. These results highlight the interplay between GAIN and 7TM domains, offering mechanistic insights and guiding pharmacological strategies to modulate aGPCR activation and signaling.
- Open Access
Dual-mode intramolecular agonist-dependent mechanoactivation of the adhesion GPCR ADGRG1/GPR56
SUMMARY PARAGRAPH: Mechanical stimuli instruct cardinal cellular decisions pertaining to their fate, proliferation, morphology, and movement 1,2 . How adhesion G protein-coupled receptors (aGPCRs), a large family of mechanosensors with more than 30 members in humans 3–5 , transduce mechanical cues into metabotropic commands, has been a matter of debate due to the lack of suitable approaches to analyze receptor activation during mechanotransduction in live cells 6 . Here we use human ADGRG1/GPR56 (G1), an aGPCR with roles in brain development 7 , skeletal muscle 8 , and platelet function 9 , to study the events during aGPCR mechanotransduction. We show that G1 dissociation, taking place at ∼18 pN (ref. 10 ), occurs at retracting fibers during cell migration over an adhesive substrate 11 , an effect that can be enhanced by cell stretching. Simultaneous live recording of G protein recruitment through total internal reflection fluorescence (TIRF) imaging and pharmacological assays during force transmission onto G1 show graded receptor responses with sub-maximal signaling before receptor dissociation, and maximal activation thereafter. Both modes require the intramolecular agonist/Stachel element 12,13 of the receptor. Our findings demonstrate that non-dissociative and dissociative aGPCR signaling can emerge from the same aGPCR depending on mechanical stimulus magnitude, demonstrating the capability of aGPCRs for graded receptor responses upon force detection.
Open AccessDual-mode intramolecular agonist-dependent mechanoactivation of the adhesion GPCR ADGRG1/GPR56
SUMMARY PARAGRAPH: Mechanical stimuli instruct cardinal cellular decisions pertaining to their fate, proliferation, morphology, and movement 1,2 . How adhesion G protein-coupled receptors (aGPCRs), a large family of mechanosensors with more than 30 members in humans 3–5 , transduce mechanical cues into metabotropic commands, has been a matter of debate due to the lack of suitable approaches to analyze receptor activation during mechanotransduction in live cells 6 . Here we use human ADGRG1/GPR56 (G1), an aGPCR with roles in brain development 7 , skeletal muscle 8 , and platelet function 9 , to study the events during aGPCR mechanotransduction. We show that G1 dissociation, taking place at ∼18 pN (ref. 10 ), occurs at retracting fibers during cell migration over an adhesive substrate 11 , an effect that can be enhanced by cell stretching. Simultaneous live recording of G protein recruitment through total internal reflection fluorescence (TIRF) imaging and pharmacological assays during force transmission onto G1 show graded receptor responses with sub-maximal signaling before receptor dissociation, and maximal activation thereafter. Both modes require the intramolecular agonist/Stachel element 12,13 of the receptor. Our findings demonstrate that non-dissociative and dissociative aGPCR signaling can emerge from the same aGPCR depending on mechanical stimulus magnitude, demonstrating the capability of aGPCRs for graded receptor responses upon force detection.
- Open Access
- 10 September 2025
- Published by Edinburgh University Library in IUPHAR/BPS Guide to Pharmacology CITE
- Vol. 2025 (3)
Adhesion Class GPCRs in GtoPdb v.2025.3
Adhesion GPCRs are structurally identified on the basis of a large extracellular region, similar to the Class B GPCR, but which is linked to the 7TM region by a GPCR autoproteolysis-inducing (GAIN) domain [15] containing a GPCR proteolysis site (GPS). The N-terminal extracellular region often shares structural homology with adhesive domains (e.g. cadherins, immunolobulin, lectins) facilitating inter- and matricellular interactions and leading to the term adhesion GPCR [120, 468]. Several receptors have been suggested to function as mechanosensors [355, 322, 442, 49, 327]. Cryo-EM structures of the 7-transmembrane domain of several adhesion GPCRs have been determined recently [326, 31, 450, 241, 334, 336, 490, 327]. The nomenclature of these receptors was revised in 2015 as recommended by NC-IUPHAR and the Adhesion GPCR Consortium [145].
- 10 September 2025
- Published by Edinburgh University Library in IUPHAR/BPS Guide to Pharmacology CITE
- Vol. 2025 (3)
Open AccessAdhesion Class GPCRs in GtoPdb v.2025.3
Adhesion GPCRs are structurally identified on the basis of a large extracellular region, similar to the Class B GPCR, but which is linked to the 7TM region by a GPCR autoproteolysis-inducing (GAIN) domain [15] containing a GPCR proteolysis site (GPS). The N-terminal extracellular region often shares structural homology with adhesive domains (e.g. cadherins, immunolobulin, lectins) facilitating inter- and matricellular interactions and leading to the term adhesion GPCR [120, 468]. Several receptors have been suggested to function as mechanosensors [355, 322, 442, 49, 327]. Cryo-EM structures of the 7-transmembrane domain of several adhesion GPCRs have been determined recently [326, 31, 450, 241, 334, 336, 490, 327]. The nomenclature of these receptors was revised in 2015 as recommended by NC-IUPHAR and the Adhesion GPCR Consortium [145].
- Open Access
- 15 July 2025
- Published by Springer Nature in Research Square
Mechanistic insights into adhesion GPCR autoproteolysis by a multiscale computational approach
In cis-autoproteolysis, proteins self-catalyze cleavage of their peptide chains. In the GAIN domain of adhesion G protein-coupled receptors, cis-autoproteolysis yields a tethered agonist critical for receptor activation. Contrary to current reaction models, the GAIN HL|T catalytic triad is insufficient for cleavage. Here, we investigated the cleavage mechanism in the rat ADGRL1 GAIN domain using multiscale modeling combining molecular dynamics and QM/MM simulations to investigate cis-autoproteolysis as a once-in-a-lifetime event. We present an updated and unique GAIN domain cis-autoproteolysis mechanism. The initial N-O acyl shift proceeds via a hydroxy-oxazolidine intermediate, sterically shifting subsequent reaction steps away from the triad base HGPS.-2. Water on its opposing side, coordinated by acidic residue E656H6.50, is essential for completing the N-O acyl shift facilitating ester hydrolysis. Our study provides detailed mechanistic insights into cis-autoproteolysis, highlighting how conserved residues and structured water networks adjacent to the triad enable a chemically precise reaction within an inherently flexible protein not evolutionarily optimized for high catalytic rate. These findings deepen our understanding of aGPCR processing and may apply broadly to other autoproteolytic proteins, offering a framework to explore similarly elusive one-time cleavage events in biology.
- 15 July 2025
- Published by Springer Nature in Research Square
Open AccessMechanistic insights into adhesion GPCR autoproteolysis by a multiscale computational approach
In cis-autoproteolysis, proteins self-catalyze cleavage of their peptide chains. In the GAIN domain of adhesion G protein-coupled receptors, cis-autoproteolysis yields a tethered agonist critical for receptor activation. Contrary to current reaction models, the GAIN HL|T catalytic triad is insufficient for cleavage. Here, we investigated the cleavage mechanism in the rat ADGRL1 GAIN domain using multiscale modeling combining molecular dynamics and QM/MM simulations to investigate cis-autoproteolysis as a once-in-a-lifetime event. We present an updated and unique GAIN domain cis-autoproteolysis mechanism. The initial N-O acyl shift proceeds via a hydroxy-oxazolidine intermediate, sterically shifting subsequent reaction steps away from the triad base HGPS.-2. Water on its opposing side, coordinated by acidic residue E656H6.50, is essential for completing the N-O acyl shift facilitating ester hydrolysis. Our study provides detailed mechanistic insights into cis-autoproteolysis, highlighting how conserved residues and structured water networks adjacent to the triad enable a chemically precise reaction within an inherently flexible protein not evolutionarily optimized for high catalytic rate. These findings deepen our understanding of aGPCR processing and may apply broadly to other autoproteolytic proteins, offering a framework to explore similarly elusive one-time cleavage events in biology.
- Open Access
- 2 January 2025
- Published by Taylor & Francis in Journal of Neurogenetics
- Vol. 39 (1) , 23-38
Drosophila WDFY3 / Bchs overexpression impairs neural function
Pathogenic variants in WDFY3, a gene encoding for an autophagy adaptor termed ALFY, are linked to neurodevelopmental delay and altered brain size in human probands. While the role of WDFY3 loss-of-function is extensively studied in neurons, little is known about the effects of WDFY3 upregulation in different cell types of the central nervous system (CNS). We show that overexpression of the Drosophila melanogaster WDFY3 ortholog, Bchs, in either glia or neurons impaired autophagy and locomotion. Bchs glial overexpression also increased VNC size and glial nuclei number significantly, whereas neuronal Bchs overexpression affected wing and thorax morphology. We identified 79 genes that were differentially expressed and overlapped in flies that overexpress Bchs in glial and neuronal cells, respectively. Additionally, upon neuronal Bchs overexpression differentially expressed genes clustered in gene ontology categories associated with autophagy and mitochondrial function. Our data indicate that glial as well as neuronal Bchs upregulation can have detrimental outcomes on neural function.
- 2 January 2025
- Published by Taylor & Francis in Journal of Neurogenetics
- Vol. 39 (1) , 23-38
Open AccessDrosophila WDFY3 / Bchs overexpression impairs neural function
Pathogenic variants in WDFY3, a gene encoding for an autophagy adaptor termed ALFY, are linked to neurodevelopmental delay and altered brain size in human probands. While the role of WDFY3 loss-of-function is extensively studied in neurons, little is known about the effects of WDFY3 upregulation in different cell types of the central nervous system (CNS). We show that overexpression of the Drosophila melanogaster WDFY3 ortholog, Bchs, in either glia or neurons impaired autophagy and locomotion. Bchs glial overexpression also increased VNC size and glial nuclei number significantly, whereas neuronal Bchs overexpression affected wing and thorax morphology. We identified 79 genes that were differentially expressed and overlapped in flies that overexpress Bchs in glial and neuronal cells, respectively. Additionally, upon neuronal Bchs overexpression differentially expressed genes clustered in gene ontology categories associated with autophagy and mitochondrial function. Our data indicate that glial as well as neuronal Bchs upregulation can have detrimental outcomes on neural function.